Research Education Core
Research Education Core
批准号:
10327915
负责人:
Shailesh Singh
金额:
$22.67万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
未结题
起止时间:
2005-09-30 至 2026-08-31
关键词:
African AmericanAgeAlabamaAptitudeBiomedical ResearchCancer Research ProjectCareer MobilityCaringClinical ResearchColorectal CancerCommunicationCommunitiesComprehensive Cancer CenterDiagnosisDiverse WorkforceEducationEducational ActivitiesEducational CurriculumEvaluationExposure toFacultyFeedbackFellowshipFundingFutureGoalsGrantHealthHealthcareHigh School StudentImmersionIncidenceInformaticsInfrastructureInstitutionInterviewJointsLaboratoriesLatinxLearningLinkMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMedicalMedical StudentsMentorsMethodsMinority GroupsMorehouse School of MedicineMovementOutcomePatientsPoliciesPostdoctoral FellowPublicationsResearchResearch PersonnelResearch Project GrantsSchoolsScienceScientistStructureStudentsTimeTrainingUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesanticancer researchbasecancer educationcancer health disparitycancer therapycancer typecareercareer developmentcollegeeducation researchethnic diversityethnic minority populationexperiencegraduate studenthands on researchhealth disparityhigh schoolimprovedinterestmembermenmortalityoutreachprogramsracial and ethnicracial and ethnic disparitiesracial diversityrecruitresponserural arearural settingskillssocial mediastatisticssummer programundergraduate studentunderserved minorityurban areaurban setting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROGRAM SUMMARY: RESEARCH EDUCATION CORE
(This Core is identical for all three Partnering Institutions)
The Partnership between Morehouse School of Medicine (MSM)/Tuskegee University (TU)/University of
Alabama at Birmingham O’Neal Comprehensive Cancer Center (MSM/TU/UAB OCCC) presents a distinctive
opportunity to build on our successful accomplishments in education of future cancer research scientists moving
through our pipeline, with an emphasis on underrepresented racial/ethnic minorities. In this U54 renewal
application, we propose a seamless integration of our cancer education programs by focusing on “hard”
(structured courses/training developed through previous U54 funding) and “soft” skills (e.g., career
development roadmap, interviewing skills) needed to facilitate movement through our pipeline into the cancer
research continuum, with the goal of having a diverse workforce in cancer research. This will be accomplished
through the following specific aims: Aim 1. To develop and implement integrated cancer research education
programs to link high school, undergraduate, and graduate/medical students with postdoctoral fellows, medical
residents, and Early Stage Investigators (ESIs), and senior-level researchers/mentors with a particular focus on
underrepresented racial/ethnic minorities in science. Four integrated programs will be utilized: (a) the Granting
Research Opportunities in Wellness by Creating Exciting Learning Laboratories in Science (GROW CELLS)
for high school students; (b) the Cancer Research Immersion Student Program (CRISP) for undergraduate
students; (c) the Summer Cancer Research Education Program (SCREP) for graduate and medical students;
and (d) the Health Disparities Research Education Program (HDREP) for medical residents, postdoctoral
fellows, and ESIs. Aim 2. To link all levels of cancer research scholars with the Outreach Core to share their
research findings with community members, obtain community feedback on relevant topics for future research
(e.g., Cancer Info Cafés), and develop publications and communications for lay audiences (e.g., blogs or posts
on social media, YouTube videos, policy briefs). Aim 3. To implement a mixed-method, triangulated evaluation
of the proposed research education activities across the pipeline. These efforts will increase the recruitment and
retention of underrepresented minorities in science, specifically in cancer research, that are congruent with the
goals expressed in the NIH’s Interest in Diversity Statement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-CCL25 mAb to treat castration resistant prostate cancer
-
批准号:9264953
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2017
-
负责人:Shailesh Singh
-
依托单位:
Anti-CXCL13 mAb to mitigate prostate cancer health disparities
-
批准号:8998175
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2015
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:8918551
-
项目类别:
-
资助金额:$18.39万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:9340094
-
项目类别:
-
资助金额:$9.58万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:9137633
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:8585726
-
项目类别:
-
资助金额:$21.23万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:8728793
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of CCL25-CCR9 in Prostate Cancer
-
批准号:8638910
-
项目类别:
-
资助金额:$35.38万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of CCL25-CCR9 in Prostate Cancer
-
批准号:8414694
-
项目类别:
-
资助金额:$35.38万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Prostate Cancer Chemoprevention using a Natural Agent
-
批准号:8445062
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Research Education Core
-
批准号:10693359
-
项目类别:
-
资助金额:$22.22万
-
财政年份:2005
-
负责人:Shailesh Singh
-
依托单位:
Research Education Core
-
批准号:10007640
-
项目类别:
-
资助金额:$14.75万
-
财政年份:2005
-
负责人:Shailesh Singh
-
依托单位:
Research Education Core
-
批准号:9368967
-
项目类别:
-
资助金额:$27.48万
-
财政年份:--
-
负责人:Shailesh Singh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: